Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-050847
Filing Date
2014-07-09
Accepted
2014-07-09 19:56:07
Documents
1
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4014
  Complete submission text file 0001104659-14-050847.txt   5398
Mailing Address C/O AEGERION PHARMACEUTICALS 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 14968147

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8444
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations